Trial Profile
Randomized phase 2 trial of treatment of advanced non small cell lung carcinoma with/without disulfiram and cisplatin navelbine [vinorelbine].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Disulfiram (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Ora Bio
- 30 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 12 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.